Intensive treatment of hyperglycemia in the acute phase of myocardial infarction: the tenuous balance between effectiveness and safety - a systematic review and meta-analysis of randomized clinical trials.
Paulo H NegreirosAdriana A BauWilson Nadruz JuniorOtávio Rizzi Coelho-FilhoJosé Roberto Matos SouzaOtavio R CoelhoAndrei Carvalho SpositoLuiz Sérgio Fernandes de CarvalhoPublished in: Revista da Associacao Medica Brasileira (1992) (2019)
This meta-analysis suggests that there may be a tenuous line between the effectiveness and safety of reducing blood glucose in the acute phase of MI. The targets must not exceed a reduction greater than 36 mg/dL in relation to estimated average blood glucose.